Dabogratinib

dabogratinib · Tyra Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dabogratinib, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma [Phase 2]

See pricing